Roivant Sciences (ROIV) Shares Outstanding (Diluted Average) (2021 - 2026)

Roivant Sciences has reported Shares Outstanding (Diluted Average) for 6 years, with the latest figure at $693.9 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) fell 4.35% year-over-year to $693.9 million; the trailing twelve-month figure through Mar 2026 stood at $693.9 million (down 4.35% YoY), and the FY2026 full-year result was $693.9 million, down 4.35% from the prior year.
• Shares Outstanding (Diluted Average) for Q1 2026 stood at $693.9 million, roughly flat from $696.9 million in the prior quarter.
• The five-year high for Shares Outstanding (Diluted Average) was $831.0 million in Q1 2024, with the low at $669.8 million in Q1 2022.
• Historically, Shares Outstanding (Diluted Average) has averaged $728.6 million across 5 years, with a median of $712.8 million in 2023.
• Annual changes were most pronounced in 2023 — Shares Outstanding (Diluted Average) increased 17.25% — and 2025, when it dropped 12.97%.
• Roivant Sciences' Shares Outstanding (Diluted Average) stood at $703.1 million in 2022, then gained by 17.25% to $824.3 million in 2023, then dropped by 11.28% to $731.3 million in 2024, then declined by 4.71% to $696.9 million in 2025, then dropped by 0.43% to $693.9 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $693.9 million (Q1 2026), $696.9 million (Q4 2025), and $680.6 million (Q3 2025), per Business Quant data.